Inception Fertility partners with tech companies to advance reproductive medicine

Inception Fertility’s clinical research team have partnered with technology companies on four fertility studies to elevate the patient experience and enhance pregnancy outcomes.

Led by Alice Domar, PhD, chief compassion officer at the US fertility company Inception, the clinical research team is designed to give the company tools to better understand and treat a range of fertility issues, empowering aspiring parents through improved education and more precise treatment options.

Inception is the largest provider of fertility services and practices in North America and uses technology, innovation and vertical integration to help patients undergoing IVF, looking for donors or partnering with a gestational carrier.

It draws participants from its ecosystem of companies to take part in new studies that have the potential to elevate sciences and advancements in assisted reproductive technologies.

“Inception proudly leads the industry once again through thoughtful and impactful studies that will help us, and the entire fertility community, understand some of the most complex aspects of fertility care, including mental health,” said TJ Farnsworth, founder and CEO of Inception Fertility.

“Our partnerships with leading technology companies allow us to keep fertility patients, including their experiences and outcomes, at the centre of our mission.”

Current studies include the OTO Device Research Study, Gameto Research Study, Lotus Research Study, and Oura Research Study.